Stemtech annual ebitda
2021
2022
2023
2024
2025
Stemtech EBITDA Growth & History (STEK)
Stemtech's calculated EBITDA was −$2.5M for fiscal 2025.
View full Stemtech company overviewStemtech annual ebitda history
| Fiscal year | Period ended | EBITDA | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | −$2.5M | −$499,591 | — |
| 2024 | 2024-12-31 | −$2.0M | $1.6M | — |
| 2023 | 2023-12-31 | −$3.6M | $939,243 | — |
| 2022 | 2022-12-31 | −$4.6M | −$1.8M | — |
| 2021 | 2021-12-31 | −$2.8M | — | — |
Stemtech quarterly ebitda
Q2.21
Q3.21
Q3.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | EBITDA | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | −$83,694 | $175,417 | — |
| Q1 2026 | 2026-03-31 | −$1.1M | $110,653 | — |
| Q4 2025 | 2025-12-31 | −$822,072 | −$1.0M | — |
| Q3 2025 | 2025-09-30 | −$297,340 | $419,130 | — |
| Q2 2025 | 2025-06-30 | −$259,111 | $427,864 | — |
| Q1 2025 | 2025-03-31 | −$1.2M | −$306,353 | — |
| Q4 2024 | 2024-12-31 | $218,160 | $1.5M | — |
| Q3 2024 | 2024-09-30 | −$716,470 | −$296,035 | — |
| Q2 2024 | 2024-06-30 | −$686,975 | $126,727 | — |
| Q1 2024 | 2024-03-31 | −$856,676 | $274,736 | — |
| Q4 2023 | 2023-12-31 | −$1.3M | −$956,182 | — |
| Q3 2023 | 2023-09-30 | −$420,435 | $2.8M | — |
| Q2 2023 | 2023-06-30 | −$813,702 | $104,895 | — |
| Q1 2023 | 2023-03-31 | −$1.1M | −$1.1M | — |
| Q4 2022 | 2022-12-31 | −$315,020 | $319,618 | — |
| Q3 2022 | 2022-09-30 | −$3.3M | −$2.5M | — |
| Q2 2022 | 2022-06-30 | −$918,597 | −$1.3M | — |
| Q1 2022 | 2022-03-31 | −$73,402 | — | — |
| Q3 2021 · Sep 30 | 2021-09-30 | −$634,638 | — | — |
| Q3 2021 · Jun 30 | 2021-06-30 | −$780,537 | — | — |
| Q2 2021 · Mar 31 | 2021-03-31 | $351,220 | — | — |
Stemtech ebitda trends
Across the available reported history, Stemtech's ebitda decreased from −$2.0M to −$2.5M, a change of −$499,591. The latest reported quarter, Q2 2026, shows −$83,694.
About the metric
What EBITDA means
EBITDA is a measure of operating performance before interest, taxes, depreciation, and amortization. It can help compare operating results, but it is not a substitute for cash flow or GAAP net income.
Calculation and source
How TickerStat calculates EBITDA
TickerStat calculates EBITDA as operating income plus reported depreciation and amortization for aligned fiscal periods. It is calculated data, not adjusted EBITDA or company guidance. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Stemtech filings at SEC.gov ↗